Evidence map›Paper›PMID 36220328›Full record

ArticleLupus science & medicine2022

Changes in cardiorespiratory function and fatigue following 12 weeks of exercise training in women with systemic lupus erythematosus: a pilot study.

Sarfaraz Hasni, Li Rebekah Feng, Marquis Chapman, Sarthak Gupta, Anam Ahmad, Adam Munday, Mir Ali Mazhar, Xiaobai Li, Shajia Lu, Wanxia Li Tsai and 10 more

Abstract read
In one paragraph

Article in Lupus science & medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. VOLupus · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sarfaraz HasniLupus Clinical Trials Unit, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA sarfaraz.hasni@nih.gov.ORCID 0000-0002-4164-8837
Li Rebekah FengNational Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Marquis ChapmanLupus Clinical Trials Unit, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Sarthak GuptaSystemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Anam AhmadRehabilitation Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Adam MundayLupus Clinical Trials Unit, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Mir Ali MazharLupus Clinical Trials Unit, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Xiaobai LiBiostatistics and Clinical Epidemiology service, National Institutes of Health Clinical Center, Bethesda, MD, USA.
Shajia LuTranslational Immunology Section, National Institute of Arthritis, and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Wanxia Li TsaiTranslational Immunology Section, National Institute of Arthritis, and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Massimo GadinaTranslational Immunology Section, National Institute of Arthritis, and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Michael DavisLupus Clinical Trials Unit, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Jun ChuLupus Clinical Trials Unit, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Zerai MannaLupus Clinical Trials Unit, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Shuichiro NakaboSystemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Mariana J KaplanSystemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-2968-0815
Leorey SaliganNational Institutes of Health, Bethesda, Maryland, USA.
Randall KeyserRehabilitation Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Leighton ChanRehabilitation Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Lisa M K ChinRehabilitation Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.

Funding

Systemic AutoimmunityZIAAR041199 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI KAPLAN, MARIANA · 2014 to 2025
$32.5M
Investigating Correlates of Fatigue in Cancer Patients receiving TreatmentZIANR000020 · NINR · NATIONAL INSTITUTE OF NURSING RESEARCH · PI SALIGAN, LEOREY · 2011 to 2022
$15.1M
Pilot Study Characterizing Aerobic Exercise in Women with Systemic Lupus Erythematosus (Exercise SLE Pilot)ZIACL060096 · CLC · CLINICAL CENTER · PI CHAN, LEIGHTON · 2020 to 2025
$0k
Intramural NIH HHS ZIA AR041199Intramural NIH HHS ZIA CL060096Intramural NIH HHS ZIA NR000020
6 · The paper itself

Abstract

objectiveIn patients with systemic lupus erythematosus (SLE), fatigue is a debilitating symptom with poorly understood pathophysiology. Cardiorespiratory dysfunction has been hypothesised as a contributor to SLE-fatigue. The purpose of this exploratory study was to examine changes in cardiorespiratory function, following an exercise training programme in women with SLE, together with patient reported outcomes and other pathophysiological measures that may underlie SLE-fatigue.

methodsSixteen women with SLE and fatigue (Fatigue Severity Scale (FSS) ≥3) were enrolled in a supervised aerobic exercise training programme of vigorous intensity. The primary outcome was time to reach anaerobic threshold (AT-Time) during a cardiopulmonary exercise test (CPET). Secondary outcomes included changes in the 10-minute walk test (10MWT), FSS scores and the Patient Reported Outcomes Measurement Information System (PROMIS-57) survey. Mitochondrial function was assessed by the oxygen consumption rate (OCR)/extracellular acidification rate (ECAR) metabolic potential ratio.

resultsFollowing 12 weeks of exercise training, AT-Time increased by 93±82 (mean±SD) s (p<0.001), 10MWT increased by 84±66 m (p<0.001) and peak oxygen uptake (VO

conclusionsCardiorespiratory function was improved in concomitance with reductions in fatigue following a 12-week aerobic exercise programme. The reduction in fatigue scores correlated with improvements in mitochondrial function.

Indexed as

Lupus Erythematosus, SystemicExerciseFatigueFemaleHumansInterferonsOxygenPilot ProjectsInterferonsOxygenexercise therapylupus erythematosus, systemicquality of lIfe

Identifiers

PMID36220328
PMCPMC9557301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.